Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 11/20 | 0.45 |
| ▸ | AVPR1B | P47901 | 8/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7412254 | 0.90 | AVPR1B (0.48) | AVPR1AAVPR1BPLG | |
| SCHEMBL7417563 | 0.90 | ITGB3 (0.39) | — | |
| SCHEMBL7422540 | 0.89 | ITGB3 (0.42) | — | |
| SCHEMBL7412563 | 0.88 | AVPR1B (0.51) | AVPR1AAVPR1BPLG | |
| SCHEMBL7415329 | 0.86 | ITGB3 (0.35) | AVPR1A | |
| SCHEMBL7416867 | 0.86 | NPSR1 (0.40) | — | |
| SCHEMBL7419767 | 0.86 | CYP3A4 (0.44) | — | |
| SCHEMBL7415180 | 0.85 | CYP3A4 (0.45) | — | |
| SCHEMBL7694791 | 0.84 | MMP2 (0.45) | — | |
| SCHEMBL7408422 | 0.84 | ITGB1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | disclosed |
| EP-1159262-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000047552-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |